Drug Topics
SEPTEMBER 21, 2023
A new study from Ohio State University found that the majority of TikTok content with information about gynecologic cancer was false or inaccurate.
Fierce Healthcare
SEPTEMBER 21, 2023
Federal regulators have accused a major Texas-based anesthesia provider and its parent private equity firm of a decade-long, three-pronged scheme to suppress competition and drive-up prices. | U.S. Anesthesia Partners and Welsh, Carson, Anderson & Stowe, its private equity backer, have "cost Texans tens of millions of dollars more each year" by suppressing competition over the course of a decade, the regulator alleges.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
SEPTEMBER 21, 2023
Independent veterinary pharmacists face competition from retail giants like Chewy and Amazon. To compete, they emphasize personalized service, compounding, and educating customers about their capabilities.
STAT
SEPTEMBER 21, 2023
The Federal Trade Commission has sued U.S. Anesthesia Partners and its private equity owner, Welsh, Carson, Anderson & Stowe, alleging in federal court the two partners formed a monopoly in order to drive up prices and boost their profits. Normally, the FTC sues the company that it believes has violated antitrust law. But this lawsuit is novel by also going after a private equity sponsor that it believes hatched the entire alleged scheme — and could serve as a warning to other private
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
SEPTEMBER 21, 2023
The ‘life-years gained from screening–computed tomography’ lung cancer screening model is recommended by the American College of Chest Physicians for personalizing patients’ shared decision-making in screening for lung cancer.
STAT
SEPTEMBER 21, 2023
An advisory panel to the Food and Drug Administration unanimously voted against a diabetes implant from Intarcia Therapeutics — a former biotech unicorn that faltered after the FDA rejected said implant not once, but twice. Intarcia called for the panel meeting because of those two rejections, seeking outside input on the FDA’s decision.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
SEPTEMBER 21, 2023
When Sarah, a mother of two, was diagnosed with breast cancer in 2021 at the age of 43, she carefully considered where to go for care. She had been referred by her doctor to Beth Israel Deaconess Medical Center, where she received a mammogram and the cancer diagnosis. But Sarah, who asked that her last name not be used, ultimately chose the Dana-Farber Cancer Institute, wanting a place that was known for cancer treatment.
Fierce Healthcare
SEPTEMBER 21, 2023
Despite a recent leadership shakeup and sub-par third quarter financial results, Walgreens’ executives maintain that its transformation from a retail store to a full-blown healthcare company is the | Walgreens execs gave reporters a peek behind the curtain at its Chicago primary care office and micro-fulfillment center. Here's what we learned.
PharmaVoice
SEPTEMBER 21, 2023
Launched this month, Brixadi from Braeburn gives patients a new tool to overcome addiction.
Fierce Healthcare
SEPTEMBER 21, 2023
Artificial intelligence soared to the top spot in an annual survey that measures what emerging technology excites hospital executives as having the potential to transform the industry. | Hospital executives in a new survey called AI the most exciting emerging technology, while patient care replaced patient access as to what respondents most want technology to tackle.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Pharma
SEPTEMBER 21, 2023
Looking to establish a “hub” in the cell therapy ecosystem, the Novo Nordisk Foundation is pumping 950 million Danish kroner (about $136 million) into a new clinical production site at the Technica | Looking to establish a “hub” in the cell therapy ecosystem, the Novo Nordisk Foundation is pumping 950 million Danish kroner (about $136 million) into a new clinical production site at the Technical University of Denmark (DTU) in Lyngby.
Pharmacy Times
SEPTEMBER 21, 2023
Pharmacist discusses the success of a unique employee-owned pharmacy model.
STAT
SEPTEMBER 21, 2023
This week, the Coalition of Kaiser Permanente Unions is negotiating a new national contract with the health care giant. More than 75,000 Kaiser Permanente health care workers across the country have voted to authorize a strike if Thursday and Friday’s bargaining sessions do not end in an acceptable deal. If announced, the strike will affect the more than 12 million people served by Kaiser’s 39 hospitals and 715 medical offices in California, Colorado, Oregon, Washington, Hawaii, Ge
Pharmacy Times
SEPTEMBER 21, 2023
Continuous glucose monitors can significantly improve the lives of patients with diabetes, offering less finger pokes, improved compliance, and easier use methods.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
SEPTEMBER 21, 2023
The SPC waiver: How do we restore the intended balance between protection and innovation? Mike.
Pharmacy Times
SEPTEMBER 21, 2023
The approval of pembrolizumab with brachytherapy could aid individuals who were newly diagnosed with progressive cervical cancer.
pharmaphorum
SEPTEMBER 21, 2023
Smartphone app cuts racial disparity in post-birth care Phil.
Pharmacy Times
SEPTEMBER 21, 2023
Implementing these standards can be logistically challenging.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
SEPTEMBER 21, 2023
Travere Therapeutics said Thursday that a study meant to confirm the benefit of its newly approved drug for a rare kidney disorder narrowly failed. In the trial, 404 patients with the disorder, IgA nephropathy, were randomized to receive either Travere’s daily pill, Filspari, or irbesartan, a decades-old blood pressure drug often used to help manage the disease.
Drug Store News
SEPTEMBER 21, 2023
WalletHub has released its 2023’s States that Vaccinate the Most report.
European Pharmaceutical Review
SEPTEMBER 21, 2023
A new Denmark-based manufacturing facility is set to establish the final development steps and upscaling of cell therapies. To establish it, the Novo Nordisk Foundation is committing up to £127 million. CEO of the Novo Nordisk Foundation Cellerator, Thomas HR Carlsen, told EPR that for cell therapy manufacturing, “The biggest challenge is producing high-quality, consistent cell therapies at the scale required for use in clinical trials… biological complexity [of living cells] means that the man
Pharmaceutical Technology
SEPTEMBER 21, 2023
The US FDA has accepted Takeda’s NDA resubmission for TAK-721 for the short-term treatment of eosinophilic esophagitis (EoE), for review.
STAT
SEPTEMBER 21, 2023
Can the FDA be too flexible? How do you test a mechanical womb? And who decides what’s good enough for patients in need? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Lizzy Lawrence joins us to explain the promise of artificial wombs and the debate over how to ethically develop them.
Fierce Healthcare
SEPTEMBER 21, 2023
CommonSpirit Health announced this week the launch of a value-based care platform that will spread and support best practices learned during recent years across the Catholic giant’s 24-state footpr | Called Population Health Services Organization, the platform will leverage the nonprofit health system's scale and recent learnings to bolster networks across its 24-state footprint, execs say.
STAT
SEPTEMBER 21, 2023
The prestigious Lasker Awards for biomedical research are sometimes referred to as “America’s Nobel,” and with good reason — about a fourth of Lasker laureates have gone on to receive the Swedish award, too. The winners of the 2023 awards, announced on Thursday in New York, distinguished themselves in AI-enabled protein modeling, groundbreaking eye test technology, and in a wide-ranging career in medical science that combined innovative discoveries with attention to m
pharmaphorum
SEPTEMBER 21, 2023
Roche inks pipeline deals with Orionis, PeptiDream Phil.
European Pharmaceutical Review
SEPTEMBER 21, 2023
A new report published by the Center for Global Development (CGD) has highlighted the need for coordinated global action against antimicrobial resistance (AMR). Experts from organisations such as the Wellcome Trust and Africa Centres for Disease Control and Prevention contributed to the paper, urging governments, industry and international organisations to create a political agreement, or ‘Grand Bargain’, to improve innovation, access, and stewardship for antimicrobials, particularly in low- and
pharmaphorum
SEPTEMBER 21, 2023
Novo Nordisk Foundation pledges €127m for cell therapy plant Phil.
The Guardian - Pharmaceutical Industry
SEPTEMBER 21, 2023
Competition watchdog probes claims of profiteering by US drugmaker in country where tuberculosis is biggest killer South Africa’s Competition Commission will investigate the American drugmaker Johnson & Johnson for the high price it has been charging for the tuberculosis medicine bedaquiline, as well as for extending its 20-year patent until 2027 to block cheaper generics from entering the country.
pharmaphorum
SEPTEMBER 21, 2023
Cancer Research UK earmarks £123m for Scottish R&D Phil.
STAT
SEPTEMBER 21, 2023
WASHINGTON — In a striking display of discord Thursday, leaders of the Senate’s health committee clashed over a proposal to increase the number of primary care doctors and nurses in the United States. In drafting the policy, Chair Bernie Sanders (I-Vt.) circumvented Sen. Bill Cassidy (R-La.), the Republican leader on the panel. He instead negotiated with a lower-ranked Republican on the committee to produce the legislation, which Cassidy then refused to support.
Drug Store News
SEPTEMBER 21, 2023
Held in partnership with ECRM and RangeMe, the summit will consist of 15- to 30-minute virtual presentations from selected suppliers.
Pharmaceutical Commerce
SEPTEMBER 21, 2023
Deal aims to provide diabetes treatment to patients across the continent.
Expert insights. Personalized for you.
503 
Let's personalize your content